Irving M. Cohen

508 total citations
24 papers, 403 citations indexed

About

Irving M. Cohen is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Irving M. Cohen has authored 24 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Nephrology. Recurrent topics in Irving M. Cohen's work include Blood Pressure and Hypertension Studies (5 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Analytical Methods in Pharmaceuticals (3 papers). Irving M. Cohen is often cited by papers focused on Blood Pressure and Hypertension Studies (5 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Analytical Methods in Pharmaceuticals (3 papers). Irving M. Cohen collaborates with scholars based in United States and Israel. Irving M. Cohen's co-authors include Daniel T. O’Connor, Wolfgang Vogel, Sanford E. Warren, Gregory M. Kochak, William D. Mason, Nathaniel Winer, John A. Mitas, Richard A. Stone, Arthur D. Hagan and W. Victor R. Vieweg and has published in prestigious journals such as Annals of Internal Medicine, Cancer and Brain Research.

In The Last Decade

Irving M. Cohen

24 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irving M. Cohen United States 12 166 61 48 47 47 24 403
J Naestoft Denmark 14 162 1.0× 98 1.6× 57 1.2× 65 1.4× 23 0.5× 20 716
D. Arndts Germany 12 79 0.5× 43 0.7× 63 1.3× 89 1.9× 35 0.7× 27 414
Duncan E. Hutcheon United States 13 86 0.5× 42 0.7× 22 0.5× 76 1.6× 65 1.4× 45 450
Mckeen Cattell United States 10 151 0.9× 80 1.3× 32 0.7× 73 1.6× 35 0.7× 25 483
M. S. Laher Ireland 11 204 1.2× 57 0.9× 18 0.4× 41 0.9× 70 1.5× 32 382
Torsten Ryman Sweden 12 109 0.7× 36 0.6× 56 1.2× 63 1.3× 70 1.5× 19 505
M.B. Meyer United States 10 180 1.1× 121 2.0× 30 0.6× 49 1.0× 35 0.7× 13 439
Allen A. Lai United States 17 97 0.6× 46 0.8× 127 2.6× 86 1.8× 133 2.8× 25 852
C Valori Italy 7 332 2.0× 76 1.2× 43 0.9× 113 2.4× 36 0.8× 20 606
P.J.D. Snow United Kingdom 10 244 1.5× 73 1.2× 24 0.5× 57 1.2× 39 0.8× 20 568

Countries citing papers authored by Irving M. Cohen

Since Specialization
Citations

This map shows the geographic impact of Irving M. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irving M. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irving M. Cohen more than expected).

Fields of papers citing papers by Irving M. Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irving M. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irving M. Cohen. The network helps show where Irving M. Cohen may publish in the future.

Co-authorship network of co-authors of Irving M. Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Irving M. Cohen. A scholar is included among the top collaborators of Irving M. Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irving M. Cohen. Irving M. Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matzdorff, Axel, et al.. (1993). Effect of Recombinant Aprotinin on Platelet Activation in Patients Undergoing Open Heart Surgery. Pathophysiology of Haemostasis and Thrombosis. 23(6). 293–300. 10 indexed citations
2.
Cohen, Irving M., Sanford E. Warren, & W. Ronald Skowsky. (1984). Occult Pulmonary Malignancy in Syndrome of Inappropriate ADH Secretion with Normal ADH Levels. CHEST Journal. 86(6). 929–931. 6 indexed citations
3.
Mitas, John A., et al.. (1984). Remission and exacerbation of tumor-related nephrotic syndrome with treatment of the neoplasm. Cancer. 54(6). 1082–1084. 13 indexed citations
4.
Cohen, Irving M., et al.. (1983). Acute renal failure following repeated streptokinase therapy for pulmonary embolism.. PubMed. 138(6). 878–80. 15 indexed citations
5.
O’Connor, Daniel T., et al.. (1983). Baroreflex dysfunction in patients with adult-onset diabetes and hypertension. The American Journal of Medicine. 74(2). 233–242. 18 indexed citations
6.
Warren, Sanford E., Daniel T. O’Connor, & Irving M. Cohen. (1983). Autonomic and baroreflex function after captopril in hypertension. American Heart Journal. 105(6). 1002–1008. 38 indexed citations
7.
O’Connor, Daniel T., et al.. (1982). Hypertension in Adult Onset Diabetes Mellitus: Abnormal Renal Hemodynamics and Endogenous Vasoregulatory Factors. American Journal of Kidney Diseases. 2(2). 271–280. 11 indexed citations
8.
Warren, Sanford E., Daniel T. O’Connor, Irving M. Cohen, & John A. Mitas. (1981). Renal hemodynamic changes during long-term antihypertensive therapy. Clinical Pharmacology & Therapeutics. 29(3). 310–317. 25 indexed citations
9.
Cohen, Irving M., Daniel T. O’Connor, Richard A. Preston, & Richard A. Stone. (1981). Long-term clonidine effects on autonomic function in essential hypertensive man. European Journal of Clinical Pharmacology. 19(1). 25–32. 12 indexed citations
10.
Hagan, Arthur D., John A. Mitas, A Mazzoleni, et al.. (1981). Clinical correlates in hypertensive patients with left ventricular hypertrophy diagnosed with echocardiography. The American Journal of Cardiology. 47(2). 335–341. 41 indexed citations
11.
Mason, William D., Gregory M. Kochak, Nathaniel Winer, & Irving M. Cohen. (1980). Effect of Exercise on Renal Clearance of Atenolol. Journal of Pharmaceutical Sciences. 69(3). 344–345. 8 indexed citations
12.
Warren, Sanford E., et al.. (1979). Mechanism of action of hydro chlorothiazide and guanabenz. Kidney International. 16(6). 924. 1 indexed citations
13.
Winer, Nathaniel, et al.. (1979). Effects of atenolol on blood pressure, heart rate, renin, and norepinephrine during exercise. Clinical Pharmacology & Therapeutics. 26(3). 315–325. 10 indexed citations
14.
Mason, William D., et al.. (1979). Kinetics and absolute bioavailability of atenolol. Clinical Pharmacology & Therapeutics. 25(4). 408–415. 100 indexed citations
15.
Vogel, Wolfgang & Irving M. Cohen. (1977). Effects of tryptamine on the conditioned avoidance response in rats. Brain Research. 122(1). 162–164. 8 indexed citations
16.
Cohen, Irving M., et al.. (1977). Combined valvular aortic stenosis, hypertrophic subaortic stenosis and coronary artery disease: successful surgical correction.. PubMed. 18(3). 241–6. 5 indexed citations
17.
Cohen, Irving M., et al.. (1976). Danger in Nitroprusside Therapy. Annals of Internal Medicine. 85(2). 205–206. 3 indexed citations
18.
19.
Cohen, Irving M. & Wolfgang Vogel. (1972). Determination and physiological disposition of dimethyltryptamine and diethyltryptamine in rat brain, liver and plasma. Biochemical Pharmacology. 21(8). 1214–1216. 33 indexed citations
20.
Cohen, Irving M. & Wolfgang Vogel. (1970). An assay procedure for mescaline and its determination in rat brain, liver and plasma. Cellular and Molecular Life Sciences. 26(11). 1231–1232. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Naestoft Breakdown of academic impact, for papers by D. Arndts Breakdown of academic impact, for papers by Duncan E. Hutcheon Breakdown of academic impact, for papers by Mckeen Cattell Breakdown of academic impact, for papers by M. S. Laher Breakdown of academic impact, for papers by Torsten Ryman Breakdown of academic impact, for papers by M.B. Meyer Breakdown of academic impact, for papers by Allen A. Lai Breakdown of academic impact, for papers by C Valori Breakdown of academic impact, for papers by P.J.D. Snow
Rankless by CCL
2026